Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 3Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Lymphoid 1CNS 1

Conditions

Neoplasms 1Motor Activity 1Lung Neoplasms 1Hodgkin Disease 1Cardiovascular Diseases 1Brain Neoplasms 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Physical Conditioning, Human × Clear all
NCT04636255 2026-05-04

Physical Capacity in Hodgkin Lymphoma Survivors

University of Sao Paulo General Hospital

Phase NA Completed
40 enrolled
Lymphoid

Cardiovascular Diseases, Hodgkin Disease

NCT02749877 2019-03-19

Efficacy of Cognitive and Physical Trainings in Pediatric Cancer Survivors

Insel Gruppe AG, University Hospital Bern

Phase NA Completed
81 enrolled
CNS

Brain Neoplasms, Motor Activity, Neoplasms

NCT01748981 2019-02-12

FALC

Oslo University Hospital

Phase NA Completed
71 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡